4 completed, 4 unknown, 1 recruiting, 1 suspended. 11 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Completed 4, Unknown 4, Recruiting 1, Suspended 1, Withdrawn 1 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Recurrent Pregnancy Loss: new trials by email Literature Review of Recurrent Pregnancy Loss trials Research Report on Recurrent Pregnancy Loss
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Recombinant Human G-CSF in Women With Unexplained Recurrent Miscarriage Placebo control, Recombinant G-CSF - Recurrent Pregnancy Loss, Recurrent Miscarriages | Phase 2 | Recruiting | Fakih IVF Fertility Center | 150 | 2026-07-10 | 2026-07-24 |
| Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells Mesenchymal stem cells capable of differentiation in the endometrial-decidual direction, Standard treatment according to the clinical protocols - Recurrent Pregnancy Loss | Phase 1 / Phase 2 | Unknown | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 20 | 2022-11-01 | 2022-08-29 |
| Intravenous Immunoglobulin and Prednisolone for RPL After ART. Human Intravenous Immunoglobulins, (Privigen (R), CLS Behring), Prednisolone Tablets, Human Albumin Solution - Habitual Abortion, Recurrent Pregnancy Loss | Phase 2 | Completed | Aalborg University Hospital | 80 | 2021-01-28 | 2025-11-24 |
| Effect of Sildenafil Citrate on Mid Luteal Phase Uterine Artery Blood Flow in Patients With Recurrent Pregnancy Loss Sildenafil 25Mg Tablet, Placebo Oral Tablet - Recurrent Pregnancy Loss | Phase 2 | Completed | Ain Shams University | 80 | 2018-09-05 | 2021-01-22 |
| Assessing the Endometrial Environment in Recurrent Pregnancy Loss and Unexplained Infertility Uterine ERA and microbiome testing, Oral antibiotics and vaginal probiotics - Recurrent Pregnancy Loss, Unexplained Infertility | Phase 2 | Completed | Stanford University | 41 | 2017-08-01 | 2025-04-01 |
| Immunomodulatory Effects of IVIg on Pregnancy Rate of Patient With Recurrent Pregnancy Loss IVIg - Recurrent Pregnancy Loss | Phase 2 | Completed | Tabriz University of Medical Sciences | 50 | 2016-09-20 | 2018-09-17 |
| Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss Hydroxychloroquine (HCQ), Placebo - Recurrent Pregnancy Loss, Miscarriage | Phase 2 | Withdrawn | University of Utah | 2016-07-01 | 2016-08-12 | |
| A Multi-center, Placebo-controlled Study to Evaluate NT100 in Pregnant Women With a History of Unexplained Recurrent Pregnancy Loss (RPL) NT100, Placebo - Recurrent Pregnancy Loss, Recurrent Miscarriage | Phase 2 | Unknown | Nora Therapeutics, Inc. | 150 | 2014-06-01 | 2015-07-15 |
| Comparison of Standard ART Practice vs. Trophectoderm Biopsy and Whole Chromosome Analysis Next Generation Sequencing after Blastocyst biopsy - Infertility, Recurrent Pregnancy Loss | Phase 2 | Unknown | Reprogenetics | 240 | 2013-09-01 | 2014-09-09 |
| Preimplantation Genetic Diagnosis Using Blastocyst Biopsy and Array CGH PGD - Infertility, Recurrent Pregnancy Loss | Phase 2 | Suspended | Reprogenetics | 200 | 2012-03-01 | 2013-08-21 |
| Aspirin Versus Clopidogrel Effect on Uterine Blood Flow in Women With Unexplained Recurrent Miscarriages Aspirin, Clopidogrel - Recurrent Pregnancy Loss | Phase 2 / Phase 3 | Unknown | Ain Shams University | 32 | 2012-03-01 | 2017-03-10 |
Abortion, Spontaneous (6) · Abortion, Habitual (3) · Infertility (2)
Female Urogenital Diseases and Pregnancy Complications (6) · Pregnancy Complications (6) · Urogenital Diseases (6) · Genital Diseases (2)
Immunoglobulins, Intravenous (2) · Anti-Bacterial Agents (1) · Aspirin (1) · Clopidogrel (1) · Hydroxychloroquine (1) · Prednisolone (1) · Prostaglandins D (1) · Sildenafil Citrate (1) · Tablets (1)
Ain Shams University (2) · Reprogenetics (2) · Aalborg University Hospital (1) · Fakih IVF Fertility Center (1) · Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus (1) · Nora Therapeutics, Inc. (1) · Stanford University (1) · Tabriz University of Medical Sciences (1) · University of Utah (1)
United States (4) · Egypt (2) · Belarus (1) · Denmark (1) · Iran (1) · United Arab Emirates (1) · United Kingdom (1)
Santiago Munne, PhD (2) · Andrei Hancharou, Dr (1) · Mehdi Yousefi, Immunologist (1) · Mohamed I Ellaithy, M.D. (1) · Mohammad Nouri, Ph.D (1) · Ole B Christiansen (1) · Robert Silver, MD (1)
PMID 12765346, PMID 17166218, PMID 19710204, PMID 19819893, PMID 21095154, PMID 22889462, PMID 24628478, PMID 30776296, PMID 32898291, PMID 36137638, PMID 41263919